Literature DB >> 12229983

Disease mapping of stage-specific cancer incidence data.

Leonhard Knorr-Held1, Günter Ralsser, Nikolaus Becker.   

Abstract

We propose two approaches for the spatial analysis of cancer incidence data with additional information on the stage of the disease at time of diagnosis. The two formulations are extensions of commonly used models for multicategorical response data on an ordinal scale. We include spatial and age-group effects in both formulations, which we estimate in a nonparametric smooth way. More specifically, we adopt a fully Bayesian approach based on Gaussian pairwise difference priors where additional smoothing parameters are treated as unknown as well. We argue that the methods are useful in monitoring the effectiveness of mass cancer screening and illustrate this through an application to data on cervical cancer in the former German Democratic Republic. The results suggest that there are large spatial differences in the stage proportions, which indicate spatial variability with respect to the introduction and effectiveness of Pap smear screening programs.

Entities:  

Mesh:

Year:  2002        PMID: 12229983     DOI: 10.1111/j.0006-341x.2002.00492.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  3 in total

1.  A Poisson-multinomial spatial model for simultaneous outbreaks with application to arboviral diseases.

Authors:  Alexandra M Schmidt; Laís P Freitas; Oswaldo G Cruz; Marilia S Carvalho
Journal:  Stat Methods Med Res       Date:  2022-06-05       Impact factor: 2.494

2.  Disease mapping of early- and late-stage cancer to monitor inequalities in early detection: a study of cutaneous malignant melanoma.

Authors:  Ulf Strömberg; Brandon L Parkes; Anders Holmén; Stefan Peterson; Erik Holmberg; Amir Baigi; Frédéric B Piel
Journal:  Eur J Epidemiol       Date:  2020-04-30       Impact factor: 8.082

3.  Bayesian hierarchical models for disease mapping applied to contagious pathologies.

Authors:  Sylvain Coly; Myriam Garrido; David Abrial; Anne-Françoise Yao
Journal:  PLoS One       Date:  2021-01-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.